Measuring tumor perfusion in control and treated murine tumors: Correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography

Journal of Ultrasound in Medicine

Volumn 26, Issue 6, 2007, Pages 749-756

  Niermann, Kenneth J ^a   Fleischer, Arthur C ^a   Huamani, Jessica ^a   Yankeelov, Thomas E ^a   Kim, Dong W ^a   Wilson, Wendy D ^a   Hallahan, Dennis E ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood flow; Magnetic resonance imaging; Microbubble contrast; Sonography; Tumor

Indexed keywords

CONTRAST MEDIA; MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RATS; STATISTICAL METHODS; TUMORS; ULTRASONOGRAPHY;

ANTIANGIOGENIC CHEMOTHERAPY; BLOOD FLOW; MICROBUBBLE CONTRAST-ENHANCED SONOGRAPHY; MURINE TUMORS;

DISEASE CONTROL;

FLUORODEOXYGLUCOSE; PERFLUTREN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEMOPERFUSION; INTERMETHOD COMPARISON; LUNG CARCINOMA; MICROBUBBLE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS;

EID: 34249864501     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2007.26.6.749     Document Type: Article

References (7)

1. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29:15-18.
2. Fleischer AC, Donnelly EF, Grippo RJ, Black AS, Hallahan DE. Quantification of tumor vascularity with contrast-enhanced sonography: correlation with magnetic resonance imaging and fluorodeoxyglucose autoradiography in an implanted tumor. J Ultrasound Med 2004; 23:37-42.
3. Kiessling F, Krix M, Heilmann M, et al. Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhanced intermittent power Doppler sonography. Invest Radiol 2003; 38:516-524.
4. Padhani AR. MRI for assessing antivascular cancer treatments. Br J Radiol 2003; 76:S60-S80.
5. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10:223-232.
6. Delbeke D. Oncological applications of FDG PET imaging. J Nucl Med 1999; 40:1706-1715.
7. Cosgrove D, Eckersley R, Blomley M, Harvey C. Quantification of blood flow. Eur Radiol 2001; 11:1338-1344.